@article{425863865dcd4925ad57f24a6f6c172a,
title = "Phase 3 MAIA Study: Overall Survival (OS) Results with Daratumumab, Lenalidomide, and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (TIE-NDMM)",
keywords = "MM, transplant-ineligible, newly diagnosed multiple myeloma, daratumumab",
author = "Robert Orlowski and Thierry Facon and Shaji Kumar and Torben Plesner and Philippe Moreau and Nizar Bahlis and Supratik Basu and Hareth Nahi and Cyrille Hulin and Hang Quach and Hartmut Goldschmidt and Michael O'Dwyer and Aurore Perrot and Christopher Venner and Katja Weisel and Joseph Mace and Noopur Raje and Mourad Tiab and Margaret Macro and Laurent Frenzel and Xavier Leleu and Tahamtan Ahmadi and Jianping Wang and \{Van Rampelbergh\}, Rian and Clarissa Uhlar and Brenda Tromp and Maria Delioukina and Jessica Vermeulen and Saad Usmani",
year = "2021",
month = sep,
day = "1",
doi = "10.1016/S2152-2650(21)01950-9",
language = "English",
volume = "21",
pages = "S424--S425",
journal = "Clinical Lymphoma Myeloma and Leukemia",
issn = "2152-2650",
publisher = "Elsevier",
number = "Suppl. 1",
note = "The ninth annual meeting of the Society of Hematologic Oncology ; Conference date: 08-09-2021 Through 11-09-2021",
}